Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Prostap
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Prostap 3 DCS 11.25mg inj pre-filled syringes
0803042N0BBADAD
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 49,255 |
|
Prostap SR DCS 3.75mg inj pre-filled syringes
0803042N0BBACAC
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 12,338 |
|
Prostap PD DCS 1.88mg inj pre-filled syringes
0803042N0BBAEAG
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 3 |
|
Prostap SR 3.75mg inj vials
0803042N0BBAAAA
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 2 |
|
Prostap 3 Depot 11.25mg inj vials
0803042N0BBABAB
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.